Updated:
Hil-Cofam
Herbert Hillebrand created Hil-Cofam as the central vehicle for the family's financial and investment affairs. The office traces its roots to his acquisitions...
Hil-Cofam
Herbert Hillebrand created Hil-Cofam as the central vehicle for the family's financial and investment affairs. The office traces its roots to his acquisitions of castles and commercial properties that form the core of the family's wealth. Hil-Cofam allocates across hedge funds, infrastructure, natural resources, private credit, private equity, real estate, and startups. Confirmed holdings include multiple commercial and residential assets in Vienna and Salzburg as well as properties in Germany. The firm maintains exposure to biotech through its healthcare activities and operates in Europe and North America. It structures commitments through direct holdings, co-investments, and fund vehicles. The office employs the two managing directors who also oversee EVER Pharma. Additional structures include B.F.H. Privatstiftung and HILFOUNDATION for philanthropic activities. No dated operational events from the last 24 months appear in available records. The family maintains direct ownership of operating businesses alongside the investment office, creating an integrated governance model that separates mission-related investing from commercial portfolio decisions.
General information
Firm type
Single Family Office
Location
Region
Europe
Country
Austria
City
Salzburg
Corporate office
Salzburg, Austria
Principals
Herbert Hillebrand
Founder
Dr. Friedrich Hillebrand
Managing Director
Dr. Julia Hillebrand
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at Hil-Cofam?
Dr. Friedrich Hillebrand and Dr. Julia Hillebrand serve as managing directors and oversee day-to-day investment and operational decisions.
Where does the underlying wealth come from?
The wealth originates from Herbert Hillebrand's acquisitions of historic properties, including multiple castles and commercial buildings in Austria and Germany.
Does Hil-Cofam participate in fund commitments or only direct deals?
The firm uses a mix of direct holdings, co-investments, and fund commitments across private equity, real estate, and other asset classes.
What investment stages does Hil-Cofam typically target?
The office targets a range of stages through its startup activity and established private equity and real estate positions.
How is Hil-Cofam related to EVER Pharma?
Dr. Friedrich Hillebrand and Dr. Julia Hillebrand serve as managing directors of both Hil-Cofam and EVER Pharma.
Does Hil-Cofam maintain philanthropic structures, and how are they separated?
The firm operates B.F.H. Privatstiftung and HILFOUNDATION as separate philanthropic vehicles focused on mission-related initiatives.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: